NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

視網膜疾病治療市場:全球產業分析,規模,佔有率,成長,趨勢,及預測(2020年∼2030年)

Retinal Disorders Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

出版商 Transparency Market Research 商品編碼 974863
出版日期 內容資訊 英文 226 Pages
商品交期: 最快1-2個工作天內
價格
視網膜疾病治療市場:全球產業分析,規模,佔有率,成長,趨勢,及預測(2020年∼2030年) Retinal Disorders Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030
出版日期: 2020年10月29日內容資訊: 英文 226 Pages
簡介

本報告提供視網膜疾病治療市場相關調查,市場概要,以及各適應症,各治療等級,各劑型,各流通管道,各地區的趨勢,及加入此市場的主要企業簡介等資訊。

目錄

第1章 序文

第2章 與假設調查手法

第3章 摘要整理:全球視網膜疾病治療市場

第4章 市場概要

  • 簡介和概要
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 全球視網膜疾病治療市場分析與預測,2018年∼2030年

第5章 市場預測

  • COVID-19大流行對產業的影響
  • 臨床試驗分析
  • 法規方案
  • 開發平台分析
  • 主要的潛在客戶
  • 主要供應商及經銷商分析
  • 主要的產業活動
  • 償付方案
  • 視網膜疾病:流行病學預測

第6章 全球視網膜疾病治療市場分析與預測,各適應症

  • 簡介和定義
  • 全球視網膜疾病治療市場價值(百萬美元)預測,各適應症,2018∼2030年
    • 黃斑部病變
    • 糖尿病視網膜病變
    • 糖尿病黃斑部水腫
    • 其他
  • 各適應症全球視網膜疾病治療市場魅力分析

第7章 全球視網膜疾病治療市場分析與預測,各治療等級

  • 簡介和定義
  • 全球視網膜疾病治療市場價值(百萬美元)預測,各治療等級,2018∼2030年
    • 抗VEGF劑
    • 其他
  • 各治療等級的全球視網膜疾病治療市場魅力分析

第8章 全球視網膜疾病治療市場分析與預測,各劑型

  • 簡介和定義
  • 全球視網膜疾病治療市場價值(百萬美元)預測,各劑型,2018∼2030年
    • 凝膠
    • 眼睛解決方案
    • 膠囊&片劑
    • 眼藥
    • 軟膏
  • 各劑型全球視網膜疾病治療市場魅力分析

第9章 全球視網膜疾病治療市場分析與預測,各流通管道

  • 簡介和定義
  • 全球視網膜疾病治療市場價值(百萬美元)預測,各流通管道,2018∼2030年
    • 醫院藥局
    • 零售藥局
    • 線上銷售
  • 各流通管道的全球視網膜疾病治療市場魅力分析

第10章 全球視網膜疾病治療市場分析與預測,各地區

  • 主要調查結果
  • 各地區的全球視網膜疾病治療市場價值(百萬美元)預測
    • 美國
    • 歐洲
    • 中國
    • 俄羅斯
    • 其他地區(RoW)
  • 各地區的全球視網膜疾病治療市場魅力分析

第11章 美國的視網膜疾病治療市場分析與預測

  • 簡介
  • 美國的視網膜疾病治療市場價值(百萬美元)預測,各適應症,2018∼2030年
    • 黃斑部病變
    • 糖尿病視網膜病變
    • 糖尿病黃斑部水腫
    • 其他
  • 美國的視網膜疾病治療市場價值(百萬美元)預測,各治療等級,2018∼2030年
    • 抗VEGF劑
    • 其他
  • 美國視網膜疾病治療市場價值(百萬美元)預測,各劑型,2018∼2030年
    • 凝膠
    • 眼睛解決方案
    • 膠囊&片劑
    • 眼藥
    • 軟膏
  • 美國的視網膜疾病治療市場價值(百萬美元)預測,各流通管道,2018∼2030年
    • 醫院藥局
    • 零售藥局
    • 線上銷售
  • 美國的視網膜疾病治療市場魅力分析
    • 各適應症
    • 各治療等級
    • 各劑型
    • 各流通管道

第12章 歐洲的視網膜疾病治療市場分析與預測

第13章 中國的視網膜疾病治療市場分析與預測

第14章 俄羅斯的視網膜疾病治療市場分析與預測

  • 簡介
  • 俄羅斯的視網膜疾病治療市場價值(百萬美元)預測,各適應症,2018∼2030年
    • 黃斑部病變
    • 糖尿病視網膜病變
    • 糖尿病黃斑部水腫
    • 其他
  • 俄羅斯的視網膜疾病治療市場價值(百萬美元)預測,各治療等級,2018∼2030年
    • 抗VEGF劑
    • 其他
  • 俄羅斯的視網膜疾病治療市場價值(百萬美元)預測,各劑型,2018∼2030年
    • 凝膠
    • 眼睛解決方案
    • 膠囊&片劑
    • 眼藥
    • 軟膏
  • 俄羅斯的視網膜疾病治療市場價值(百萬美元)預測,各流通管道,2018∼2030年
    • 醫院藥局
    • 零售藥局
    • 線上銷售
  • 俄羅斯的視網膜疾病治療市場魅力分析
    • 各適應症
    • 各治療等級
    • 各劑型
    • 各流通管道

第15章 其他全球視網膜疾病治療市場分析與預測

第16章 競爭情形

  • 市場情況分析,各企業,2019年
  • 企業簡介
    • Allergan plc
    • Bayer AG
    • F. Hoffmann-La Roche Ltd.
    • Graybug Vision, Inc.
    • Kubota Pharmaceutical Holdings Co., Ltd.
    • Novartis AG
    • Pfizer, Inc.
    • Regeneron Pharmaceuticals, Inc.
    • Santen Pharmaceutical Co., Ltd.
    • Takeda Pharmaceutical Company Limited
目錄
Product Code: TMRGL79712

Title:
Retinal Disorders Treatment Market (Indication: Macular Degeneration, Diabetic Retinopathy, Diabetic Macular Edema, and Others; Therapeutic Class: Anti-VEGF Agents and Others; Dosage Form: Gels, Eye Solutions, Capsules & Tablets, Eye Drops, and Ointments; Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Sales) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030.

Retinal Disorders Treatment Market - Scope of the Report

TMR's report on the global retinal disorders treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030. The report provides the revenue of the global retinal disorders treatment market for the period 2018-2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global retinal disorders treatment market from 2020 to 2030.

The report has been prepared after extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global retinal disorders treatment market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various attributes of the global retinal disorders treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Moreover, the report sheds light on changing competitive dynamics in the global retinal disorders treatment market. These serve as valuable tools for existing market players as well as entities interested in participating in the global retinal disorders treatment market.

The report also delves into the competition landscape of the global retinal disorders treatment market. Key players operating in the global retinal disorders treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global retinal disorders treatment market that have been profiled in this report.

Key Questions Answered in Retinal Disorders Treatment Report

What is the sales/revenue generated by retinal disorders treatment providers across all regions during the forecast period?

What are the opportunities in the global retinal disorders treatment market?

What are the major drivers, restraints, opportunities, and threats in the global market?

Which region is set to expand at the fastest CAGR during the forecast period?

Which product segment is expected to generate the highest revenue globally in 2030? Which segment is projected to expand at the highest CAGR during the forecast period?

What are the market positions of different companies operating in the global market?

Retinal Disorders Treatment Market - Research Objectives and Research Approach

The comprehensive report on the global retinal disorders treatment market begins with an overview, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that have been appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global retinal disorders treatment market in terms of indication, dosage form, therapeutic class, distribution channel, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2030 has been provided. Such valuable insights enable market stakeholders to make informed business decisions for investment in the global retinal disorders treatment market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Retinal Disorders Treatment Market

4. Market Overview

  • 4.1. Introduction & Overview
  • 4.2. Market Dynamics
    • 4.2.1. Drivers
    • 4.2.2. Restraints
    • 4.2.3. Opportunities
  • 4.3. Global Retinal Disorders Treatment Market Analysis and Forecast, 2018-2030

5. Market Outlook

  • 5.1. COVID-19 Pandemics Impact on Industry
  • 5.2. Clinical Trial Analysis
  • 5.3. Regulatory Scenario
  • 5.4. Pipeline Analysis
  • 5.5. Key Potential Customers
  • 5.6. Key Vendor and Distributor Analysis
  • 5.7. Key Industry Events
  • 5.8. Reimbursement Scenario
  • 5.9. Retinal Disorders: Epidemiology Forecast

6. Global Retinal Disorders Treatment Market Analysis and Forecast, by Indication

  • 6.1. Introduction & Definition
  • 6.2. Global Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2018-2030
    • 6.2.1. Macular Degeneration
      • 6.2.1.1. Dry Macular Degeneration
      • 6.2.1.2. Wet Macular Degeneration
    • 6.2.2. Diabetic Retinopathy
    • 6.2.3. Diabetic Macular Edema
    • 6.2.4. Others
  • 6.3. Global Retinal Disorders Treatment Market Attractiveness Analysis, by Indication

7. Global Retinal Disorders Treatment Market Analysis and Forecast, by Therapeutic Class

  • 7.1. Introduction & Definition
  • 7.2. Global Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2018-2030
    • 7.2.1. Anti-VEGF Agents
    • 7.2.2. Others
  • 7.3. Global Retinal Disorders Treatment Market Attractiveness Analysis, by Therapeutic Class

8. Global Retinal Disorders Treatment Market Analysis and Forecast, by Dosage Form

  • 8.1. Introduction & Definition
  • 8.2. Global Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018-2030
    • 8.2.1. Gels
    • 8.2.2. Eye Solutions
    • 8.2.3. Capsules & Tablets
    • 8.2.4. Eye Drops
    • 8.2.5. Ointments
  • 8.3. Global Retinal Disorders Treatment Market Attractiveness Analysis, by Dosage Form

9. Global Retinal Disorders Treatment Market Analysis and Forecast, by Distribution Channel

  • 9.1. Introduction & Definition
  • 9.2. Global Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
    • 9.2.1. Hospital Pharmacies
    • 9.2.2. Retail Pharmacies
    • 9.2.3. Online Sales
  • 9.3. Global Retinal Disorders Treatment Market Attractiveness Analysis, by Distribution Channel

10. Global Retinal Disorders Treatment Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Global Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Region
    • 10.2.1. U.S.
    • 10.2.2. Europe
    • 10.2.3. China
    • 10.2.4. Russia
    • 10.2.5. Rest of the World (RoW)
  • 10.3. Global Retinal Disorders Treatment Market Attractiveness Analysis, by Region

11. U.S. Retinal Disorders Treatment Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. U.S. Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2018-2030
    • 11.2.1. Macular Degeneration
      • 11.2.1.1. Dry Macular Degeneration
      • 11.2.1.2. Wet Macular Degeneration
    • 11.2.2. Diabetic Retinopathy
    • 11.2.3. Diabetic Macular Edema
    • 11.2.4. Others
  • 11.3. U.S. Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2018-2030
    • 11.3.1. Anti-VEGF Agents
    • 11.3.2. Others
  • 11.4. U.S. Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018-2030
    • 11.4.1. Gels
    • 11.4.2. Eye Solutions
    • 11.4.3. Capsules & Tablets
    • 11.4.4. Eye Drops
    • 11.4.5. Ointments
  • 11.5. U.S. Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
    • 11.5.1. Hospital Pharmacies
    • 11.5.2. Retail Pharmacies
    • 11.5.3. Online Sales
  • 11.6. U.S. Retinal Disorders Treatment Market Attractiveness Analysis
    • 11.6.1. By Indication
    • 11.6.2. By Therapeutic Class
    • 11.6.3. By Dosage Form
    • 11.6.4. By Distribution Channel

12. Europe Retinal Disorders Treatment Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Europe Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2018-2030
    • 12.2.1. Macular Degeneration
      • 12.2.1.1. Dry Macular Degeneration
      • 12.2.1.2. Wet Macular Degeneration
    • 12.2.2. Diabetic Retinopathy
    • 12.2.3. Diabetic Macular Edema
    • 12.2.4. Others
  • 12.3. Europe Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2018-2030
    • 12.3.1. Anti-VEGF Agents
    • 12.3.2. Others
  • 12.4. Europe Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018-2030
    • 12.4.1. Gels
    • 12.4.2. Eye Solutions
    • 12.4.3. Capsules & Tablets
    • 12.4.4. Eye Drops
    • 12.4.5. Ointments
  • 12.5. Europe Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
    • 12.5.1. Hospital Pharmacies
    • 12.5.2. Retail Pharmacies
    • 12.5.3. Online Sales
  • 12.6. Europe Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Spain
    • 12.6.5. Italy
    • 12.6.6. Rest of Europe
  • 12.7. Europe Retinal Disorders Treatment Market Attractiveness Analysis
    • 12.7.1. By Indication
    • 12.7.2. By Therapeutic Class
    • 12.7.3. By Dosage Form
    • 12.7.4. By Distribution Channel
    • 12.7.5. By Country/Sub-region

13. China Retinal Disorders Treatment Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. China Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2018-2030
    • 13.2.1. Macular Degeneration
      • 13.2.1.1. Dry Macular Degeneration
      • 13.2.1.2. Wet Macular Degeneration
    • 13.2.2. Diabetic Retinopathy
    • 13.2.3. Diabetic Macular Edema
    • 13.2.4. Others
  • 13.3. China Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2018-2030
    • 13.3.1. Anti-VEGF Agents
    • 13.3.2. Others
  • 13.4. China Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018-2030
    • 13.4.1. Gels
    • 13.4.2. Eye Solutions
    • 13.4.3. Capsules & Tablets
    • 13.4.4. Eye Drops
    • 13.4.5. Ointments
  • 13.5. China Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
    • 13.5.1. Hospital Pharmacies
    • 13.5.2. Retail Pharmacies
    • 13.5.3. Online Sales
  • 13.6. China Retinal Disorders Treatment Market Attractiveness Analysis
    • 13.6.1. By Indication
    • 13.6.2. By Therapeutic Class
    • 13.6.3. By Dosage Form
    • 13.6.4. By Distribution Channel

14. Russia Retinal Disorders Treatment Market Analysis and Forecast

  • 14.1. Introduction
  • 14.2. Russia Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2018-2030
    • 14.2.1. Macular Degeneration
      • 14.2.1.1. Dry Macular Degeneration
      • 14.2.1.2. Wet Macular Degeneration
    • 14.2.2. Diabetic Retinopathy
    • 14.2.3. Diabetic Macular Edema
    • 14.2.4. Others
  • 14.3. Russia Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2018-2030
    • 14.3.1. Anti-VEGF Agents
    • 14.3.2. Others
  • 14.4. Russia Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018-2030
    • 14.4.1. Gels
    • 14.4.2. Eye Solutions
    • 14.4.3. Capsules & Tablets
    • 14.4.4. Eye Drops
    • 14.4.5. Ointments
  • 14.5. Russia Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
    • 14.5.1. Hospital Pharmacies
    • 14.5.2. Retail Pharmacies
    • 14.5.3. Online Sales
  • 14.6. Russia Retinal Disorders Treatment Market Attractiveness Analysis
    • 14.6.1. By Indication
    • 14.6.2. By Therapeutic Class
    • 14.6.3. By Dosage Form
    • 14.6.4. By Distribution Channel

15. Rest of the World Retinal Disorders Treatment Market Analysis and Forecast

  • 15.1. Introduction
  • 15.2. Rest of the World Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2018-2030
    • 15.2.1. Macular Degeneration
      • 15.2.1.1. Dry Macular Degeneration
      • 15.2.1.2. Wet Macular Degeneration
    • 15.2.2. Diabetic Retinopathy
    • 15.2.3. Diabetic Macular Edema
    • 15.2.4. Others
  • 15.3. Rest of the World Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2018-2030
    • 15.3.1. Anti-VEGF Agents
    • 15.3.2. Others
  • 15.4. Rest of the World Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018-2030
    • 15.4.1. Gels
    • 15.4.2. Eye Solutions
    • 15.4.3. Capsules & Tablets
    • 15.4.4. Eye Drops
    • 15.4.5. Ointments
  • 15.5. Rest of the World Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
    • 15.5.1. Hospital Pharmacies
    • 15.5.2. Retail Pharmacies
    • 15.5.3. Online Sales
  • 15.6. Rest of the World Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
    • 15.6.1. Canada
    • 15.6.2. India
    • 15.6.3. Japan
    • 15.6.4. Australia
    • 15.6.5. Brazil
    • 15.6.6. Rest of Rest of the World
  • 15.7. Rest of the World Retinal Disorders Treatment Market Attractiveness Analysis
    • 15.7.1. By Indication
    • 15.7.2. By Therapeutic Class
    • 15.7.3. By Dosage Form
    • 15.7.4. By Distribution Channel
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Position Analysis, by Company, 2019
  • 16.2. Company Profiles
    • 16.2.1. Allergan plc
      • 16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.1.2. Growth Strategies
      • 16.2.1.3. SWOT Analysis
    • 16.2.2. Bayer AG
      • 16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.2.2. Growth Strategies
      • 16.2.2.3. SWOT Analysis
    • 16.2.3. F. Hoffmann-La Roche Ltd.
      • 16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.3.2. Growth Strategies
      • 16.2.3.3. SWOT Analysis
    • 16.2.4. Graybug Vision, Inc.
      • 16.2.4.1. Company Overview (HQ, Business Segments)
      • 16.2.4.2. Growth Strategies
      • 16.2.4.3. SWOT Analysis
    • 16.2.5. Kubota Pharmaceutical Holdings Co., Ltd.
      • 16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.5.2. Growth Strategies
      • 16.2.5.3. SWOT Analysis
    • 16.2.6. Novartis AG
      • 16.2.6.1. Company Overview (HQ, Business Segments)
      • 16.2.6.2. Growth Strategies
      • 16.2.6.3. SWOT Analysis
    • 16.2.7. Pfizer, Inc.
      • 16.2.7.1. Company Overview (HQ, Business Segments)
      • 16.2.7.2. Growth Strategies
      • 16.2.7.3. SWOT Analysis
    • 16.2.8. Regeneron Pharmaceuticals, Inc.
      • 16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.8.2. Growth Strategies
      • 16.2.8.3. SWOT Analysis
    • 16.2.9. Santen Pharmaceutical Co., Ltd.
      • 16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.9.2. Growth Strategies
      • 16.2.9.3. SWOT Analysis
    • 16.2.10. Takeda Pharmaceutical Company Limited
      • 16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.10.2. Growth Strategies
      • 16.2.10.3. SWOT Analysis

List of Tables

  • Table 01: Global Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2018-2030
  • Table 02: Global Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2018-2030
  • Table 03: Global Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018-2030
  • Table 04: Global Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 05: Global Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Region, 2018-2030
  • Table 06: U.S. Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2018-2030
  • Table 07: U.S. Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2018-2030
  • Table 08: U.S. Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018-2030
  • Table 09: U.S. Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 10: Europe Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2018-2030
  • Table 11: Europe Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2018-2030
  • Table 12: Europe Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018-2030
  • Table 13: Europe Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 14: Europe Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 15: China Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2018-2030
  • Table 16: China Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2018-2030
  • Table 17: China Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018-2030
  • Table 18: China Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 19: Russia Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2018-2030
  • Table 20: Russia Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2018-2030
  • Table 21: Russia Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018-2030
  • Table 22: Russia Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 23: Rest of the World (ROW) Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Indication, 2018-2030
  • Table 24: Rest of the World (ROW) Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2018-2030
  • Table 25: Rest of the World (ROW) Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2018-2030
  • Table 26: Rest of the World (ROW) Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 27: Rest of the World (ROW) Retinal Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030

List of Figures

  • Figure 01: Global Retinal Disorders Treatment Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 02: Global Retinal Disorders Treatment Market Value Share, by Indication, 2019
  • Figure 03: Global Retinal Disorders Treatment Market Value Share, by Dosage Form, 2019
  • Figure 04: Global Retinal Disorders Treatment Market Value Share, by Therapeutic Class, 2019
  • Figure 05: Global Retinal Disorders Treatment Market Value Share, by Distribution Channel, 2019
  • Figure 06: Global Retinal Disorders Treatment Market Value Share, by Region, 2019
  • Figure 07: Clinical Trial Analysis, by Phase
  • Figure 08: Clinical Trial Analysis, by Status
  • Figure 09: Clinical Trial Analysis, by Completion and Termination Rate
  • Figure 10: Clinical Trial Analysis, by Region
  • Figure 11: Global Retinal Disorders Treatment Market Value Share Analysis, by Indication, 2019 and 2030
  • Figure 12: Global Retinal Disorders Treatment Market Attractiveness Analysis, by Indication, 2020-2030
  • Figure 13: Global Retinal Disorders Treatment Market Value (US$ Mn), by Macular Degeneration, 2018-2030
  • Figure 14: Global Retinal Disorders Treatment Market Value (US$ Mn), by Diabetic Retinopathy, 2018-2030
  • Figure 15: Global Retinal Disorders Treatment Market Value (US$ Mn), by Diabetic Macular Edema, 2018-2030
  • Figure 16: Global Retinal Disorders Treatment Market Value (US$ Mn), by Others (retinal vein occlusion, etc.), 2018-2030
  • Figure 17: Global Retinal Disorders Treatment Market Value Share Analysis, by Therapeutic Class, 2019 and 2030
  • Figure 18: Global Retinal Disorders Treatment Market Attractiveness Analysis, by Therapeutic Class, 2020-2030
  • Figure 19: Global Retinal Disorders Treatment Market Value (US$ Mn), by Anti-VEGF Agents, 2018-2030
  • Figure 20: Global Retinal Disorders Treatment Market Value (US$ Mn), by Others (anti-inflammatory drugs, etc.), 2018-2030
  • Figure 21: Global Retinal Disorders Treatment Market Value Share Analysis, by Dosage Form, 2019 and 2030
  • Figure 22: Global Retinal Disorders Treatment Market Attractiveness Analysis, by Dosage Form, 2020-2030
  • Figure 23: Global Retinal Disorders Treatment Market Value (US$ Mn), by Gels, 2018-2030
  • Figure 24: Global Retinal Disorders Treatment Market Value (US$ Mn), by Eye Solutions, 2018-2030
  • Figure 25: Global Retinal Disorders Treatment Market Value (US$ Mn), by Capsules & Tablets, 2018-2030
  • Figure 26: Global Retinal Disorders Treatment Market Value (US$ Mn), by Eye Drops, 2018-2030
  • Figure 27: Global Retinal Disorders Treatment Market Value (US$ Mn), by Ointments, 2018-2030
  • Figure 28: Global Retinal Disorders Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 29: Global Retinal Disorders Treatment Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 30: Global Retinal Disorders Treatment Market Value (US$ Mn), by Hospital Pharmacies, 2018-2030
  • Figure 31: Global Retinal Disorders Treatment Market Value (US$ Mn), by Retail Pharmacies, 2018-2030
  • Figure 32: Global Retinal Disorders Treatment Market Value (US$ Mn), by Online Sales, 2018-2030
  • Figure 33: Global Retinal Disorders Treatment Market Value Share Analysis, by Region, 2019 and 2030
  • Figure 34: Global Retinal Disorders Treatment Market Analysis, by Region
  • Figure 35: U.S. Retinal Disorders Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 36: U.S. Retinal Disorders Treatment Market Value Share Analysis, by Indication, 2019 and 2030
  • Figure 37: U.S. Retinal Disorders Treatment Market Attractiveness Analysis, by Indication, 2020-2030
  • Figure 38: U.S. Retinal Disorders Treatment Market Value Share Analysis, by Therapeutic Class, 2019 and 2030
  • Figure 39: U.S. Retinal Disorders Treatment Market Attractiveness Analysis, by Therapeutic Class, 2020-2030
  • Figure 40: U.S. Retinal Disorders Treatment Market Value Share Analysis, by Dosage Form, 2019 and 2030
  • Figure 41: U.S. Retinal Disorders Treatment Market Attractiveness Analysis, by Dosage Form, 2020-2030
  • Figure 42: U.S. Retinal Disorders Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 43: U.S. Retinal Disorders Treatment Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 44: Europe Retinal Disorders Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 45: Europe Retinal Disorders Treatment Market Value Share Analysis, by Indication, 2019 and 2030
  • Figure 46: Europe Retinal Disorders Treatment Market Attractiveness Analysis, by Indication, 2020-2030
  • Figure 47: Europe Retinal Disorders Treatment Market Attractiveness Analysis, by Therapeutic Class, 2020-2030
  • Figure 48: Europe Retinal Disorders Treatment Market Value Share Analysis, by Dosage Form, 2019 and 2030
  • Figure 49: Europe Retinal Disorders Treatment Market Attractiveness Analysis, by Dosage Form, 2020-2030
  • Figure 50: Europe Retinal Disorders Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 51: Europe Retinal Disorders Treatment Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 52: Europe Retinal Disorders Treatment Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
  • Figure 53: Europe Retinal Disorders Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 54: China Retinal Disorders Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 55: China Retinal Disorders Treatment Market Value Share Analysis, by Indication, 2019 and 2030
  • Figure 56: China Retinal Disorders Treatment Market Attractiveness Analysis, by Indication, 2020-2030
  • Figure 57: China Retinal Disorders Treatment Market Value Share Analysis, by Therapeutic Class, 2019 and 2030
  • Figure 58: China Retinal Disorders Treatment Market Attractiveness Analysis, by Therapeutic Class, 2020-2030
  • Figure 59: China Retinal Disorders Treatment Market Value Share Analysis, by Dosage Form, 2019 and 2030
  • Figure 60: China Retinal Disorders Treatment Market Attractiveness Analysis, by Dosage Form, 2020-2030
  • Figure 61: China Retinal Disorders Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 62: China Retinal Disorders Treatment Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 63: Russia Retinal Disorders Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 64: Russia Retinal Disorders Treatment Market Value Share Analysis, by Indication, 2019 and 2030
  • Figure 65: Russia Retinal Disorders Treatment Market Attractiveness Analysis, by Indication, 2020-2030
  • Figure 66: Russia Retinal Disorders Treatment Market Value Share Analysis, by Therapeutic Class, 2019 and 2030
  • Figure 67: Russia Retinal Disorders Treatment Market Attractiveness Analysis, by Therapeutic Class, 2020-2030
  • Figure 68: Russia Retinal Disorders Treatment Market Value Share Analysis, by Dosage Form, 2019 and 2030
  • Figure 69: Russia Retinal Disorders Treatment Market Attractiveness Analysis, by Dosage Form, 2020-2030
  • Figure 70: Russia Retinal Disorders Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 71: Russia Retinal Disorders Treatment Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 72: Rest of the World (ROW) Retinal Disorders Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 73: Rest of the World (ROW) Retinal Disorders Treatment Market Value Share Analysis, by Indication, 2019 and 2030
  • Figure 74: Rest of the World (ROW) Retinal Disorders Treatment Market Attractiveness Analysis, by Indication, 2020-2030
  • Figure 75: Rest of the World (ROW) Retinal Disorders Treatment Market Value Share Analysis, by Therapeutic Class, 2019 and 2030
  • Figure 76: Rest of the World (ROW) Retinal Disorders Treatment Market Attractiveness Analysis, by Therapeutic Class, 2020-2030
  • Figure 77: Rest of the World (ROW) Retinal Disorders Treatment Market Value Share Analysis, by Dosage Form, 2019 and 2030
  • Figure 78: Rest of the World (ROW) Retinal Disorders Treatment Market Attractiveness Analysis, by Dosage Form, 2020-2030
  • Figure 79: Rest of the World (ROW) Retinal Disorders Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 80: Rest of the World (ROW) Retinal Disorders Treatment Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 81: Rest of the World (ROW) Retinal Disorders Treatment Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
  • Figure 82: Rest of the World (ROW) Retinal Disorders Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020-2030